Central nervous system and the pathogenesis of hypertension: Sites and mechanisms

Hypertension

Volumn 18, Issue 5, 1991, Pages III-7-III-12

  Brody, Michael J ^a   Varner, Kurt J ^a   Vasquez, Elisardo C ^a   Lewis, Stephen J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Aldosterone; Blood pressure; Central nervous system; Deoxycorticosterone; Spontaneously hypertensive rats

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DEOXYCORTICOSTERONE ACETATE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM; RENIN; SARALASIN; SODIUM; VASOPRESSIN;

ADRENERGIC SYSTEM; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEAFFERENTATION; HUMAN; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMAL; BRAIN; DESOXYCORTICOSTERONE; HUMAN; HYPERTENSION; HYPERTENSION, RENAL; MEDULLA OBLONGATA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025942207     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.hyp.18.5_suppl.iii7     Document Type: Article

References (42)

1. Brody MJ, Faber JE, Mangiapane ML, Porter JP: The central nervous system and prevention of hypertension, in de Jong W (ed): Handbook of Hypertension: Experimental and Genetic Models of Hypertension, Amsterdam, Elsevier/North-Holland Biomedical Press BV, 1984, vol 4, pp 474–494
2. Brody MJ, Barron KW, Berecek KH, Faber JE, Lappe RW: Nervous system and hypertension, in Genest J (ed): Hypertension: Physiopathology and Treatment, ed 2. New York, McGraw-Hill Book Co, 1983, pp 117–140
3. Simpson JB: The circumventricular organs and the central actions of angiotensin. Neuroendocrinology 1981;32:248–256
4. Ferrario CM, Barnes KL, Diz DI, Block CH, Averill DB: Role of area postrema pressor mechanisms in the regulation of arterial pressure. Can J Physiol Pharmacol 1987;65: 1591–1597
5. Johnson AK, Loewy AD: Circumventricular organs and their role in visceral functions, in Loewy AD, Syper KM (eds): Central Regulation of Autonomic Functions. New York, Oxford University Press, Inc, 1990, pp 245–267
6. van Houton M, Schiffrin EL, Mann JFE, Posner BI, Boucher R: Radioautographic localization of specific binding sites for blood-borne angiotensin II in rat brain. Brain Res 1980;186: 480–485
7. Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ: Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 1984;81: 1575–1579
8. Lind RW: Neural connections of the subfornical organ, in Gross PM (ed): Circumventricular Organs and Body Fluids. Boca Raton, Fla, CRC Press, 1987, vol 1, pp 27–42
9. Phillips MI, Camacho A: Neural connections of the organum vasculosum of the laminal terminalis, in Gross PM (ed): Circumventricular Organs and Body Fluids. Boca Raton, Fla, CRC Press, 1987, vol 1, pp 157–169
10. Fink GD, Bruner CA, Mangiapane ML: Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 1987;9:355–361
11. Fink GD, Bruner CA, Pawloski CM, Blair ML, Skoog KM, Mangiapane ML: Role of area postrema in hypertension after unilateral renal artery constriction in the rat (abstract). Fed Proc 1986;45:875
12. Sweet CS, Colombo JM, Gaul SL: Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats. Am J Physiol 1976;231:1794–1799
13. Faber JE, Brody MJ: Central nervous system action of angiotensin during onset of renal hypertension in awake rats. Am J Physiol 1984;247:349–360
14. Mann JFE, Phillis MI, Dietz R, Haebara H, Ganten D: Effects of central and peripheral angiotensin blockade in hypertensive rats. Am J Physiol 1978;234:H629–H637
15. Haywood JR, Fink GD, Buggy J, Boutelle S, Johnson AK, Brody MJ: Prevention of two-kidney, one-clip renal hypertension in rat by ablation of AV3V tissue. Am J Physiol 1983;245: H683–H689
16. Buggy J, Fink GD, Johnson AK, Brody MJ: Prevention of the development of renal hypertension by anteroventral third ventricular tissue lesions. Circ Res 1977;40(suppl I):I-110-I-117
17. Buggy J, Fink GD, Haywood JR, Johnson AK, Brody MJ: Interruption of the maintenance phase of established hypertension by ablation of the anteroventral third ventricle (AV3V) in rats. Clin Exp Hypertexts [A] 1978;1:337–353
18. Berecek KH, Barron KW, Webb RL, Brody MJ: Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension 1982;4(suppl II): II-131-II-137
19. Richardson JS: On the role of the septal area in the development of DOCA-salt hypertension in the rat. Clin Exp Hypertexts [A] 1983;A5:469–478
20. Fink GD, Pawloski CM, Blair ML, Mangiapane ML: The area postrema in deoxycorticosterone-salt hypertension in rats. Hypertension 1987;9(suppl III):III-206-III-209
21. Ciriello J: Contributions of forebrain in the maintenance of deoxycorticosterone acetate-salt hypertension. Clin Exp Hypertens [A] 1988;A10:169–178
22. Berecek KH, Murray RD, Gross F, Brody MJ: Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension 1982;4:3–12
23. Birmingham MK, Sar M, Stumpf WE: Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography. Neurochem Res 1984;9:333–350
24. Yougue BG, Roy EJ: Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: Regional distribution and effects of physiological variations in serum steroid. Brain Res 1987;436:49–61
25. Stumpf WE Sar M: Glucocorticoid and mineralocorticoid hormone target sites in the brain: Autoradiographic studies with corticosterone, aldosterone and dexamethasone, in Jones MT, Gillham B, Dallman MF, Chattopahgay S (eds): Interaction Within the Brain Pituitary-Adrenocortical System. London, Academic Press, 1979, pp 137–147
26. Arriza JE Simerly RB, Swanson LW, Evans RM: The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1988;1:887–900
27. Gomez-Sanchez EP: Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 1986;118: 819–823
28. Janiak PC, Lewis SJ, Brody MJ: Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol 1990;259:R1025–R1034
29. Reis DJ, Ruggiero DA, Morrison SF: The Cl area of the rostral ventrolateral medulla oblongata. Am J Hypertexts 1989; 2:363S-374S
30. Guyenet PG: Role of the ventral medulla oblongata in blood pressure regulation, in Loewy AD, Spyer KM (eds): Central Regulation of Autonomic Functions. New York, Oxford University Press, Inc, 1990, pp 145–167
31. Cox BF, Brody MJ: Subregions of rostral ventral medulla control arterial pressure and regional hemodynamics. Am J Physiol 1989;257:R635–R640
32. Varner KJ, Grosskreutz CE Cox BF, Brody MJ: Differential regulation of sympathetic nerve activity by lateral and medial subregions of the rostral ventral medulla. Prog Brain Res 1989;81:99–103
33. Cox BF, Brody MJ: Mechanisms of respiration-induced changes in vasomotor control exerted by RVLM. Am J Physiol 1989;257:R626–R634
34. Brody MJ, Varner KJ, Lewis SJ, Machado B, Grosskreutz CE Simon JS, Rashkin J: Are vagal preganglionic neurons located in rostral ventromedial medulla (RVMM) of rats? (abstract). FASEB J 1990;4:A556
35. Varner KJ, Vasquez EC, Brody MJ: Chemical lesion of rostral ventrolateral (RVLM) or ventromedial (RVMM) medulla prevents neurogenic hypertension (abstract). Soc Neurosci 1990,16:298
36. Krieger EM: Neurogenic hypertension in the rat. Circ Res 1964;15:511–521
37. Doba N, Reis DJ: Acute fulminating neurogenic hypertension produced by brain stem lesions in the rat. Circ Res 1973;32: 584–593
38. Ciriello J: Forebrain mechanisms in neurogenic hypertension. Can J Physiol Pharmacol 1987;65:1580–1583
39. Catelli JM, Sved AF: Lesions of the AV3V region attenuate sympathetic activation but not the hypertension elicited by destruction of the nucleus tract us solitarius. Brain Res 1988; 439:330–336
40. Vasquez EC, Varner KJ, Lewis SJ, Brody MJ: Chronic N-methyl-D-aspartic acid (NMDA) lesions of neurons in rostral ventrolateral (RVLM) and rostral ventromedial medulla (RVMM) (abstract). FASEB J 1990;4:A557
41. Smith JK, Barron KW: Cardiovascular effects of L-glutamate and tetrodotoxin microinjected into the rostral and caudal ventrolateral medulla in normotensive and spontaneously hypertensive rats. Brain Res 1990;506:1–8
42. Kubo T, Nagura J, Kihara M, Misu Y: Cardiovascular effects of L-glutamate and gamma-aminobutyric add injected into the rostral ventrolateral medulla in normotensive and spontaneously hypertensive rats. Arch Int Pharmacodyn Ther 1986;279:150–161